Terms: = Breast cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1
597 results:
1. Identification of a Panel of miRNAs Associated with Resistance to Palbociclib and Endocrine Therapy.
Torrisi R; Vaira V; Giordano L; Fernandes B; Saltalamacchia G; Palumbo R; Carnaghi C; Basilico V; Gentile F; Masci G; De Sanctis R; Santoro A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338777
[TBL] [Abstract] [Full Text] [Related]
2. Future cancer risk after urgent suspected cancer referral in England when cancer is not found: a national cohort study.
Scott SE; Gildea C; Nicholson BD; Evans RE; Waller J; Smith D; Purushotham A; Round T
Lancet Oncol; 2023 Nov; 24(11):1242-1251. PubMed ID: 37922929
[TBL] [Abstract] [Full Text] [Related]
3. Suppression of Ah Receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growth.
Elson DJ; Nguyen BD; Korjeff NA; Wilferd SF; Puig-Sanvicens V; Sang Jang H; Bernales S; Chakravarty S; Belmar S; Ureta G; Finlay D; Plaisier CL; Kolluri SK
Biochem Pharmacol; 2023 Sep; 215():115706. PubMed ID: 37506922
[TBL] [Abstract] [Full Text] [Related]
4. Opportunities for Achieving the cancer Moonshot Goal of a 50% Reduction in cancer Mortality by 2047.
Shiels MS; Lipkowitz S; Campos NG; Schiffman M; Schiller JT; Freedman ND; Berrington de González A
Cancer Discov; 2023 May; 13(5):1084-1099. PubMed ID: 37067240
[TBL] [Abstract] [Full Text] [Related]
5. A colorimetric and photothermal dual-mode biosensing platform based on nanozyme-functionalized flower-like DNA structures for tumor-derived exosome detection.
Zhang X; Zhu X; Li Y; Hai X; Bi S
Talanta; 2023 Jun; 258():124456. PubMed ID: 36940568
[TBL] [Abstract] [Full Text] [Related]
6. Integrative Pan-cancer Genomic and Transcriptomic Analyses of Refractory Metastatic cancer.
Pradat Y; Viot J; Yurchenko AA; Gunbin K; Cerbone L; Deloger M; Grisay G; Verlingue L; Scott V; Padioleau I; Panunzi L; Michiels S; Hollebecque A; Jules-Clément G; Mezquita L; Lainé A; Loriot Y; Besse B; Friboulet L; André F; Cournède PH; Gautheret D; Nikolaev SI
Cancer Discov; 2023 May; 13(5):1116-1143. PubMed ID: 36862804
[TBL] [Abstract] [Full Text] [Related]
7. p27kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer.
Mouron S; Bueno MJ; Muñoz M; Torres R; Rodríguez S; Apala JV; Silva J; Sánchez-Bayona R; Manso L; Guerra J; Rodriguez-Lajusticia L; Malon D; Malumbres M; Quintela-Fandino M
JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36806942
[TBL] [Abstract] [Full Text] [Related]
8. Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative breast cancer.
Adams CM; Mitra R; Xiao Y; Michener P; Palazzo J; Chao A; Gour J; Cassel J; Salvino JM; Eischen CM
Cancer Discov; 2023 May; 13(5):1210-1229. PubMed ID: 36734633
[TBL] [Abstract] [Full Text] [Related]
9. Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1/S phase.
Rahimi Lifshagerd M; Safari F
Clin Transl Oncol; 2023 Jun; 25(6):1702-1709. PubMed ID: 36617361
[TBL] [Abstract] [Full Text] [Related]
10. [MEN for multiple endocrin neoplasms: When evokate MEN? Update 2022].
Duval M; Haissaguerre M
Rev Med Interne; 2023 Jan; 44(1):12-18. PubMed ID: 36307322
[TBL] [Abstract] [Full Text] [Related]
11. Single-Institution Algorithm for Prevention and Management of Complications in Direct-to-Implant breast Reconstruction.
Yin Z; Wang H; Liu Y; Wang Y; Chang EI; Yin J
Plast Reconstr Surg; 2022 Oct; 150():48S-60S. PubMed ID: 35943963
[TBL] [Abstract] [Full Text] [Related]
12. Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis.
Mustafa Ali MK; Samhouri Y; Law JY; Khan C; Wegner R; Lee ST; Lister J
Breast Cancer; 2022 Nov; 29(6):1022-1031. PubMed ID: 35788963
[TBL] [Abstract] [Full Text] [Related]
13. HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.
Sgubin M; Pegoraro S; Pellarin I; Ros G; Sgarra R; Piazza S; Baldassarre G; Belletti B; Manfioletti G
Cell Death Dis; 2022 May; 13(5):429. PubMed ID: 35504904
[TBL] [Abstract] [Full Text] [Related]
14. 17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in breast cancer: A Multicenter, Randomized Controlled Trial.
Luo C; Wei C; Guo W; Yang J; Sun Q; Wei W; Wu S; Fang S; Zeng Q; Zhao Z; Meng F; Huang X; Zhang X; Li R; Ma X; Luo C; Yang Y
Adv Ther; 2022 Jun; 39(6):2961-2970. PubMed ID: 35486221
[TBL] [Abstract] [Full Text] [Related]
15. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.
El Sharouni MA; Scolyer RA; van Gils CH; Ch'ng S; Nieweg OE; Pennington TE; Saw RP; Shannon K; Spillane A; Stretch J; Witkamp AJ; Sigurdsson V; Thompson JF; van Diest PJ; Lo SN
Eur J Cancer; 2022 May; 167():133-141. PubMed ID: 35216870
[TBL] [Abstract] [Full Text] [Related]
16. UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in breast cancer Cell Lines.
Corrà F; Crudele F; Baldassari F; Bianchi N; Galasso M; Minotti L; Agnoletto C; Di Leva G; Brugnoli F; Reali E; Bertagnolo V; Vecchione A; Volinia S
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946928
[TBL] [Abstract] [Full Text] [Related]
17. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
Raj S; Ogola G; Han J
Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
[TBL] [Abstract] [Full Text] [Related]
18. Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer.
Huang Y; Wang H; Lyu Z; Dai H; Liu P; Zhu Y; Song F; Chen K
Cancer Biol Med; 2021 Sep; 19(9):1375-84. PubMed ID: 34570443
[TBL] [Abstract] [Full Text] [Related]
19. Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy.
Oner G; Önder S; Karatay H; Ak N; Tükenmez M; Müslümanoğlu M; İğci A; Dincçağ A; Özmen V; Aydiner A; Yavuz E; Cabioğlu N
World J Surg Oncol; 2021 Sep; 19(1):264. PubMed ID: 34474671
[TBL] [Abstract] [Full Text] [Related]
20. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.
Chen B; Zhang G; Lai J; Xiao W; Li X; Li C; Mok H; Li K; Wang Y; Cao L; Jia M; Ren C; Wen L; Wei G; Lin J; Li Y; Zhang Y; Chen X; Wu X; Zhang H; Li M; Liu J; Balch CM; Liao N
EBioMedicine; 2021 Sep; 71():103542. PubMed ID: 34454403
[TBL] [Abstract] [Full Text] [Related]
[Next]
